|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of sales | ||||
| Impairment expense, net of reversals | ||||
| Other cost of sales | ||||
| Gross loss | ||||
| Selling, general and administrative expense | ||||
| Research and development expense | ||||
| Other operating income (expense), net | ||||
| Listing expense | ||||
| Other operating income | ||||
| Other operating expense | ||||
| Foreign exchange gains (losses) on operating activities, net | ||||
| Operating loss | ||||
| Finance income | ||||
| Finance expense | ||||
| Fair value change - Earn-out rights | ||||
| Fair value change - Class C Shares | ||||
| Foreign exchange gains (losses) on financial activities, net | ||||
| Fair value changes - Earn-out rights and Class C shares | ||||
| Share of losses in associates | ||||
| Loss before income taxes | ||||
| Income tax benefit | ||||
| Net loss | ||||
| Net loss per share (in U.S. dollars) | ||||
| Net loss per share - basic (in dollars per share) | ||||
| Class A Shares | ||||
| Class B Shares | ||||
| Total net loss per share - basic (in dollars per share) | ||||
| Net loss per share - diluted (in dollars per share) | ||||
| Class A Shares | ||||
| Class B Shares | ||||
| Total net loss per share - diluted (in dollars per share) | ||||
| Other comprehensive income (loss) | ||||
| Items that may be subsequently reclassified to the Consolidated Statement of Comprehensive Loss: | ||||
| Exchange rate differences from translation of foreign operations | ||||
| Total other comprehensive income (loss) | ||||
| Total comprehensive loss |
Loading...